Multi-source data-driven machine learning improves lung cancer care

https://www.news-medical.net/news/20260817/Multi-source-data-driven-machine-learning-improves-lung-cancer-care.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=medtech_newsletter_24_august_2026 Section 1: Background Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide. Clinical practice has long been plagued by core dilemmas, including insufficient sensitivity in early screening, lack of personalized treatment regimens, and limited accuracy in prognostic evaluation, which severely restrict the improvement of patient survival rates. Traditional lung cancer diagnosis and treatment rely heavily on empirical judgment, which can hardly address the high heterogeneity of tumors and the complex evolution of the disease course. With the continuous accumulation of medical resources such as medical imaging, omics detection, liquid biopsy, digital pathology, and electronic health records, lung cancer management has entered a new era driven by multi-source data. Machine learning, with its powerful capabilities in data mining and pattern recognition, can extract latent patterns from complex, heterogeneous, and multi-dimensional medical data. It transforms morphological features, molecular characteristics, pathological structures, blood biomarkers, and clinical information into quantitative evidence for diagnosis, treatment decision-making, and prognosis assessment, thus becoming a key technology to break through the bottlenecks of lung cancer care.